European Journal of Clinical and Biomedical Sciences
Volume 6, Issue 1, February 2020, Pages: 5-8
Received: Dec. 28, 2019;
Accepted: Jan. 6, 2020;
Published: Jan. 17, 2020
Views 423 Downloads 121
Huang Yumin, Department of Orthopaedics, the 909th Hospital of PLA, Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhangzhou, China
Zhou Liang, Department of Orthopaedics, the 909th Hospital of PLA, Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhangzhou, China
Lin Weichang, Department of Orthopaedics, the 909th Hospital of PLA, Affiliated Southeast Hospital of Xiamen University, Orthopaedic Center of People's Liberation Army, Zhangzhou, China
This study is to explore the expression differences of vimentin in the normal spinal cord tissues and the injured spinal cord tissues. The 15 SD rats were randomly divided into two experimental groups and sham group. Acute spinal cord injury models in experimental groups were performed with Lisa method and the injured spinal cord was collected after getting injured 72h. The method of immunohistochemical stain was applied to observe the expressions of vimentin in the normal spinal cord tissue and the injured spinal cord tissue of rats. The results showed the expression of vimentin was found in both the grey matter and white matter of the spinal cord of rats with a relatively even distribution. In addition, the protein expressions of vimentin in the medium injury group and the severe injury group were obviously higher than the sham group. In conclusion, expressions of vimentin were found in the spinal cord, and expression differences were observed after the spinal cord injury, which indicated that vimentin might play a part in the injured process of the spinal cord. It is poised to be a phase of advancement in the treatment of acute spinal cord injury and the importance of further elucidation of underlying pathophysiological mechanisms of vimentin.
Expression of Vimentin in Spinal Cord Injury, European Journal of Clinical and Biomedical Sciences.
Vol. 6, No. 1,
2020, pp. 5-8.
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Chen J, Fabry B, Schiffrin EL, et al. Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. American journal of physiology Cell physiology 2001, 280 (6): C1475-1484.
Moujaber O, Stochaj U. The Cytoskeleton as Regulator of Cell Signaling Pathways. Trends in biochemical sciences 2019.
Duncan EJ, Lariviere R, Bradshaw TY, et al. Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin. Human molecular genetics 2017, 26 (16): 3130-3143.
De Souza PC, Katz SG. Coexpression of cytokeratin and vimentin in mice trophoblastic giant cells. Tissue & cell 2001, 33 (1): 40-45.
Ko SH, Suh SH, Kim BJ, et al. Expression of the intermediate filament vimentin in proliferating duct cells as a marker of pancreatic precursor cells. Pancreas 2004, 28 (2): 121-128.
Benes P, Maceckova V, Zdrahal Z, et al. Role of vimentin in regulation of monocyte/macrophage differentiation. Differentiation; research in biological diversity 2006, 74 (6): 265-276.
Dumont AS, Dumont RJ, Oskouian RJ. Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention? Current opinion in neurology 2002, 15 (6): 713-720.
Werner HB, Nave KA. Enhanced Actin Dynamics: A Therapeutic Strategy for Axonal Regeneration? Neuron 2019, 103 (6): 949-950.
Hol EM, Capetanaki Y. Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin. Cold Spring Harbor perspectives in biology 2017, 9 (12).
Parry DA. Hendecad repeat in segment 2A and linker L2 of intermediate filament chains implies the possibility of a right-handed coiled-coil structure. Journal of structural biology 2006, 155 (2): 370-374.
Dey R, Burkhard P. A proposed atomic model of the head-to-tail interaction in the filament structure of vimentin. Journal of biomolecular structure & dynamics 2019: 1-7.
Deng Z, Du WW, Fang L, et al. The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. The Journal of biological chemistry 2013, 288 (1): 319-331.
Lin J, Lu J, Wang C, et al. The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer. Cancer cell international 2017, 17: 80.
Yang L, Tang L, Dai F, et al. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-alpha-mediated endothelial apoptosis via regulating vimentin cytoskeleton. Toxicology 2017, 389: 74-84.
Byun Y, Chen F, Chang R, et al. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell death and differentiation 2001, 8 (5): 443-450.
Su L, Pan P, Yan P, et al. Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Scientific reports 2019, 9 (1): 5747.